Related references
Note: Only part of the references are listed.Interaction of the oncogenic miR-21 microRNA and the p53 tumor suppressor pathway
Xiaodong Ma et al.
CARCINOGENESIS (2013)
NFκB-mediated cyclin D1 expression by microRNA-21 influences renal cancer cell proliferation
Amit Bera et al.
CELLULAR SIGNALLING (2013)
Decreased expression of microRNA-31 associates with aggressive tumor progression and poor prognosis in patients with bladder cancer
S. Wang et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2013)
Aldose reductase inhibition suppresses colon cancer cell viability by modulating microRNA-21 mediated programmed cell death 4 (PDCD4) expression
Ashish Saxena et al.
EUROPEAN JOURNAL OF CANCER (2013)
MicroRNA-31 Sensitizes Human Breast Cells to Apoptosis by Direct Targeting of Protein Kinase C ε (PKCε)
Cindy Koerner et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
MicroRNA-31 Activates the RAS Pathway and Functions as an Oncogenic MicroRNA in Human Colorectal Cancer by Repressing RAS p21 GTPase Activating Protein 1 (RASA1)
Defang Sun et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Prognostic Implications of Serum microRNA-21 in Colorectal Cancer
Pablo Menendez et al.
JOURNAL OF SURGICAL ONCOLOGY (2013)
Expression of MicroRNAs in Patients With Pancreatic Cancer and Its Prognostic Significance
Ioannis G. Papaconstantinou et al.
PANCREAS (2013)
Deep Sequencing the MicroRNA Transcriptome in Colorectal Cancer
Kristina Schee et al.
PLOS ONE (2013)
Expression, Tissue Distribution and Function of miR-21 in Esophageal Squamous Cell Carcinoma
Nazila Nouraee et al.
PLOS ONE (2013)
Downregulation of miRNA-31 induces taxane resistance in ovarian cancer cells through increase of receptor tyrosine kinase MET
T. Mitamura et al.
ONCOGENESIS (2013)
MicroRNA Signatures in Tumor Tissue Related to Angiogenesis in Non-Small Cell Lung Cancer
Tom Donnem et al.
PLOS ONE (2012)
Independent and Tissue-Specific Prognostic Impact of miR-126 in Nonsmall Cell Lung Cancer
Tom Donnem et al.
CANCER (2011)
A 5-MicroRNA Signature for Lung Squamous Cell Carcinoma Diagnosis and hsa-miR-31 for Prognosis
Xiaogang Tan et al.
CLINICAL CANCER RESEARCH (2011)
Prognostic significance of differentially expressed miRNAs in esophageal cancer
Yuxin Hu et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
The role of miR-31 and its target gene SATB2 in cancer-associated fibroblasts
Olga Aprelikova et al.
CELL CYCLE (2010)
Pro-tumorigenic Effects of miR-31 Loss in Mesothelioma
Sergey V. Ivanov et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
MicroRNA-31 functions as an oncogenic microRNA in mouse and human lung cancer cells by repressing specific tumor suppressors
Xi Liu et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Systematic evaluation of the miRNA-ome and its downstream effects on mRNA expression identifies gastric cancer progression
Oleg Tchemitsa et al.
JOURNAL OF PATHOLOGY (2010)
MicroRNAs and Cancer: Short RNAs Go a Long Way
Andrea Ventura et al.
CELL (2009)
被撤回的出版物: A Pleiotropically Acting MicroRNA, miR-31, Inhibits Breast Cancer Metastasis (Retracted article. See vol. 161, pg. 417, 2015)
Scott Valastyan et al.
CELL (2009)
Clinicopathological significance of microRNA-31,-143 and-145 expression in colorectal cancer
Chao-Jie Wang et al.
DISEASE MARKERS (2009)
Differential expression of microRNA species in human gastric cancer versus non-tumorous tissues
Junming Guo et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2009)
Down-regulated expression of SATB2 is associated with metastasis and poor prognosis in colorectal cancer
Shuang Wang et al.
JOURNAL OF PATHOLOGY (2009)
Mature miR-184 as potential oncogenic microRNA of squamous cell carcinoma of tongue
Thian-Sze Wong et al.
CLINICAL CANCER RESEARCH (2008)
SATB2 interacts with chromatin-remodeling molecules in differentiating cortical neurons
Andrea B. Gyorgy et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2008)
Systematic analysis of microRNA expression of RNA extracted from fresh frozen and formalin-fixed paraffin-embedded samples
Yaguang Xi et al.
RNA (2007)
MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1)
Shuomin Zhu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Altered expression of miR-21, miR-31, miR-143 and miR-145 is related to clinicopathologic features of colorectal cancer
O. Slaby et al.
ONCOLOGY (2007)
Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues
E. Bandres et al.
MOLECULAR CANCER (2006)
SATB2 is a multifunctional determinant of craniofacial patterning and osteoblast differentiation
Gergana Dobreva et al.
CELL (2006)
A microRNA expression signature of human solid tumors defines cancer gene targets
S Volinia et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Clonogenic assay of cells in vitro
Nicolaas A. P. Franken et al.
NATURE PROTOCOLS (2006)
MicroRNAs: Genomics, biogenesis, mechanism, and function
DP Bartel
CELL (2004)
MicroRNAs modulate hematopoietic lineage differentiation
CZ Chen et al.
SCIENCE (2004)
Cyclooxygenase-2 expression: A significant prognostic indicator for patients with colorectal cancer
LT Soumaoro et al.
CLINICAL CANCER RESEARCH (2004)
Sulforaphane-induced G2/M phase cell cycle arrest involves checkpoint kinase 2-mediated phosphorylation of cell division cycle 25C
SV Singh et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
SUMO modification of a novel MAR-binding protein, SATB2, modulates immunoglobulin 11 3048 gene expression
G Dobreva et al.
GENES & DEVELOPMENT (2003)
Share Paper
